| Product Code: ETC14714074 | Publication Date: Jun 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Thailand Biologic Drug Market Overview |
3.1 Thailand Country Macro Economic Indicators |
3.2 Thailand Biologic Drug Market Revenues & Volume, 2022 & 2032F |
3.3 Thailand Biologic Drug Market - Industry Life Cycle |
3.4 Thailand Biologic Drug Market - Porter's Five Forces |
3.5 Thailand Biologic Drug Market Revenues & Volume Share, By Segment, 2022 & 2032F |
3.6 Thailand Biologic Drug Market Revenues & Volume Share, By Product Type, 2022 & 2032F |
3.7 Thailand Biologic Drug Market Revenues & Volume Share, By Disease Area, 2022 & 2032F |
3.8 Thailand Biologic Drug Market Revenues & Volume Share, By Manufacturing Type, 2022 & 2032F |
3.9 Thailand Biologic Drug Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Thailand Biologic Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Thailand Biologic Drug Market Trends |
6 Thailand Biologic Drug Market, By Types |
6.1 Thailand Biologic Drug Market, By Segment |
6.1.1 Overview and Analysis |
6.1.2 Thailand Biologic Drug Market Revenues & Volume, By Segment, 2022 - 2032F |
6.1.3 Thailand Biologic Drug Market Revenues & Volume, By Monoclonal Antibodies, 2022 - 2032F |
6.1.4 Thailand Biologic Drug Market Revenues & Volume, By Hormones, 2022 - 2032F |
6.1.5 Thailand Biologic Drug Market Revenues & Volume, By Cytokines, 2022 - 2032F |
6.1.6 Thailand Biologic Drug Market Revenues & Volume, By Fusion Proteins, 2022 - 2032F |
6.2 Thailand Biologic Drug Market, By Product Type |
6.2.1 Overview and Analysis |
6.2.2 Thailand Biologic Drug Market Revenues & Volume, By Recombinant, 2022 - 2032F |
6.2.3 Thailand Biologic Drug Market Revenues & Volume, By Natural, 2022 - 2032F |
6.2.4 Thailand Biologic Drug Market Revenues & Volume, By Biosimilars, 2022 - 2032F |
6.2.5 Thailand Biologic Drug Market Revenues & Volume, By Novel Biologics, 2022 - 2032F |
6.3 Thailand Biologic Drug Market, By Disease Area |
6.3.1 Overview and Analysis |
6.3.2 Thailand Biologic Drug Market Revenues & Volume, By Oncology, 2022 - 2032F |
6.3.3 Thailand Biologic Drug Market Revenues & Volume, By Endocrine Disorders, 2022 - 2032F |
6.3.4 Thailand Biologic Drug Market Revenues & Volume, By Autoimmune Diseases, 2022 - 2032F |
6.3.5 Thailand Biologic Drug Market Revenues & Volume, By Hematology, 2022 - 2032F |
6.4 Thailand Biologic Drug Market, By Manufacturing Type |
6.4.1 Overview and Analysis |
6.4.2 Thailand Biologic Drug Market Revenues & Volume, By In-house, 2022 - 2032F |
6.4.3 Thailand Biologic Drug Market Revenues & Volume, By Outsourced, 2022 - 2032F |
6.4.4 Thailand Biologic Drug Market Revenues & Volume, By Contract Manufacturing, 2022 - 2032F |
6.4.5 Thailand Biologic Drug Market Revenues & Volume, By CDMO, 2022 - 2032F |
6.5 Thailand Biologic Drug Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Thailand Biologic Drug Market Revenues & Volume, By Hospitals, 2022 - 2032F |
6.5.3 Thailand Biologic Drug Market Revenues & Volume, By Clinics, 2022 - 2032F |
6.5.4 Thailand Biologic Drug Market Revenues & Volume, By Specialty Pharmacies, 2022 - 2032F |
6.5.5 Thailand Biologic Drug Market Revenues & Volume, By Research Institutes, 2022 - 2032F |
7 Thailand Biologic Drug Market Import-Export Trade Statistics |
7.1 Thailand Biologic Drug Market Export to Major Countries |
7.2 Thailand Biologic Drug Market Imports from Major Countries |
8 Thailand Biologic Drug Market Key Performance Indicators |
9 Thailand Biologic Drug Market - Opportunity Assessment |
9.1 Thailand Biologic Drug Market Opportunity Assessment, By Segment, 2022 & 2032F |
9.2 Thailand Biologic Drug Market Opportunity Assessment, By Product Type, 2022 & 2032F |
9.3 Thailand Biologic Drug Market Opportunity Assessment, By Disease Area, 2022 & 2032F |
9.4 Thailand Biologic Drug Market Opportunity Assessment, By Manufacturing Type, 2022 & 2032F |
9.5 Thailand Biologic Drug Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Thailand Biologic Drug Market - Competitive Landscape |
10.1 Thailand Biologic Drug Market Revenue Share, By Companies, 2025 |
10.2 Thailand Biologic Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here